These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3704452)
1. Therapeutic effects of mazindol on narcolepsy. Iijima S; Sugita Y; Teshima Y; Hishikawa Y Sleep; 1986; 9(1 Pt 2):265-8. PubMed ID: 3704452 [TBL] [Abstract][Full Text] [Related]
2. [Value of mazindol in Gélineau's disease. Apropos of 10 cases]. Vespignani H; Weber M; Atlas P; Barroche G Rev Electroencephalogr Neurophysiol Clin; 1986 Oct; 16(3):317-22. PubMed ID: 3809694 [TBL] [Abstract][Full Text] [Related]
3. Mazindol in the treatment of narcolepsy. Parkes JD; Schachter M Acta Neurol Scand; 1979 Oct; 60(4):250-4. PubMed ID: 525256 [TBL] [Abstract][Full Text] [Related]
4. Amphetamine, mazindol, and fencamfamin in narcolepsy. Shindler J; Schachter M; Brincat S; Parkes JD Br Med J (Clin Res Ed); 1985 Apr; 290(6476):1167-70. PubMed ID: 2859077 [TBL] [Abstract][Full Text] [Related]
5. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review. Nittur N; Konofal E; Dauvilliers Y; Franco P; Leu-Semenescu S; Cock VC; Inocente CO; Bayard S; Scholtz S; Lecendreux M; Arnulf I Sleep Med; 2013 Jan; 14(1):30-6. PubMed ID: 23036267 [TBL] [Abstract][Full Text] [Related]
6. [Advances in the psychopharmacological management of the narcoleptic patient]. Salín-Pascual RJ; de la Fuente JR Acta Psiquiatr Psicol Am Lat; 1985 Mar; 31(1):62-8. PubMed ID: 4050495 [TBL] [Abstract][Full Text] [Related]
8. Importance of mazindol in the treatment of narcolepsy. Vespignani H; Barroche G; Escaillas JP; Weber M Sleep; 1984; 7(3):274-5. PubMed ID: 6484432 [No Abstract] [Full Text] [Related]
9. Narcolepsy in the older adult: epidemiology, diagnosis and management. Chakravorty SS; Rye DB Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996 [TBL] [Abstract][Full Text] [Related]
10. Mazindol in long-term treatment of narcolepsy. Alvarez B; Dahlitz M; Grimshaw J; Parkes JD Lancet; 1991 May; 337(8752):1293-4. PubMed ID: 1674093 [No Abstract] [Full Text] [Related]
11. Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy. Okura M; Riehl J; Mignot E; Nishino S Neuropsychopharmacology; 2000 Nov; 23(5):528-38. PubMed ID: 11027918 [TBL] [Abstract][Full Text] [Related]
12. [Narcolepsy]. Lange KW Dtsch Med Wochenschr; 1990 Aug; 115(33):1244-50. PubMed ID: 2201510 [No Abstract] [Full Text] [Related]
14. Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy. Broughton R; Mamelak M Can J Neurol Sci; 1980 Feb; 7(1):23-31. PubMed ID: 7388696 [TBL] [Abstract][Full Text] [Related]
15. Short-term and long-term clinical evaluation of a non-amphetaminic anorexiant (mazindol) in the treatment of obesity. Enzi G; Baritussio A; Marchiori E; Crepaldi G J Int Med Res; 1976; 4(5):305-18. PubMed ID: 1028632 [TBL] [Abstract][Full Text] [Related]
16. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate]. Poza-Aldea JJ Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563 [TBL] [Abstract][Full Text] [Related]
17. A double-blind trial of mazindol using a very low calorie formula diet. Baird IM; Howard AN Int J Obes; 1977; 1(3):271-8. PubMed ID: 363631 [TBL] [Abstract][Full Text] [Related]
18. Severe hypermotility during sleep in treatment of cataplexy with clomipramine. Bental E; Lavie P; Sharf B Isr J Med Sci; 1979 Jul; 15(7):607-9. PubMed ID: 478825 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride. Guilleminault C; Raynal D; Takahashi S; Carskadon M; Dement W Acta Neurol Scand; 1976 Jul; 54(1):71-87. PubMed ID: 936975 [TBL] [Abstract][Full Text] [Related]